Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tomasz J. Slebioda"'
Autor:
Tomasz J. Ślebioda, Marcin Stanisławowski, Lucyna Kaszubowska, Jan M. Zaucha, Michał A. Żmijewski
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2912 (2022)
Chimeric antigen receptor T (CAR-T) cells are genetically modified autologous T cells that have revolutionized the treatment of relapsing and refractory haematological malignancies. In this review we present molecular pathways involved in the activat
Externí odkaz:
https://doaj.org/article/f1b29ecfbd5d46f984d7f67d37b311e9
Autor:
Tomasz J. Ślebioda, Zbigniew Kmieć
Publikováno v:
Mediators of Inflammation, Vol 2014 (2014)
Externí odkaz:
https://doaj.org/article/964ecc41afdd44a08215fd1e0601b7c7
Autor:
Dorota Zurawa-Janicka, Jarek Kobiela, Marcin Stanisławowski, Andrzej J. Lachinski, Tomasz J. Slebioda, Zbigniew Sledzinski, Tomasz Wenta, Wojciech Biernat, Piotr M. Wierzbicki, Rafał Pęksa, Zbigniew Kmieć, Barbara Lipinska
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 3947, p 3947 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 11
International Journal of Molecular Sciences
Volume 21
Issue 11
HtrA proteases regulate cellular homeostasis and cell death. Their dysfunctions have been correlated with oncogenesis and response to therapeutic treatment. We investigated the relation between HtrA1-3 expression and clinicopathological, and survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44c39fbfe9616845b653125272e5957f
https://www.mdpi.com/1422-0067/21/11/3947
https://www.mdpi.com/1422-0067/21/11/3947
Autor:
Krzysztof Celiński, Piotr Landowski, Barbara Kamińska, Tomasz J. Slebioda, Marta Cyman, Agnieszka Bojarska-Junak, Zbigniew Kmieć
Publikováno v:
Cytometry Part B: Clinical Cytometry. 92:165-169
Background Interaction between TL1A and death receptor 3 (DR3) is associated with the pathogenesis of inflammatory bowel disease (IBD), although their role in the development of this disease remains not fully explained. Some studies showed elevated e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6054f01dba7d0ab4e8da92b39f9ea384
https://doi.org/10.1002/cyto.b.21372
https://doi.org/10.1002/cyto.b.21372
Autor:
Sonya James, Aymen Al-Shamkhani, Tomasz J. Slebioda, Adam F. Cunningham, Vadim Y. Taraban, Sarah L. Buchan
Publikováno v:
European Journal of Immunology. 42:580-588
The TNF receptor superfamily member death receptor 3 (DR3) exacerbates Th2- and Th17-cell-mediated inflammatory and autoimmune conditions, yet no role in host defence has been reported. Here, we examined the role of DR3 during infection with Salmonel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa6752d72d58c12697ba8986d0fc0531
https://doi.org/10.1002/eji.201041950
https://doi.org/10.1002/eji.201041950
Autor:
Jane E. Willoughby, Aymen Al-Shamkhani, Tomasz J. Slebioda, Vadim Y. Taraban, Tania F. Rowley, Sarah L. Buchan, John R. Ferdinand
Publikováno v:
European Journal of Immunology. 41:2606-2611
TNFRSF25 is a member of the TNF receptor superfamily (TNFRSF) that binds to the TNF-like protein TL1A. Although recent studies have demonstrated a role for TNFRSF25 in regulating CD4(+) T-cell responses, it remains to be determined if TNFRSF25 functi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a13c6b105b570fbeaf0400023a30a067
https://doi.org/10.1002/eji.201141477
https://doi.org/10.1002/eji.201141477
Autor:
Edward Chung Yern Wang, Tomasz J. Slebioda, Vadim Y. Taraban, Aymen Al-Shamkhani, Sarah L. Buchan, Neil Smyth, Sonya James, Jane E. Willoughby, Gareth J. Thomas, Bhavwanti Sheth
Publikováno v:
Europe PubMed Central
The tumor necrosis factor (TNF) superfamily protein TNF-like 1A (TL1A) is the ligand for death receptor 3 (DR3). TL1A is induced on activated dendritic cells (DCs) and its expression has been linked to human inflammatory bowel disease. To address how
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1871fcf03669a1cd393d80fab2088e8
https://doi.org/10.1038/mi.2010.70
https://doi.org/10.1038/mi.2010.70
Autor:
Tomasz J, Slebioda, Agnieszka, Bojarska-Junak, Marta, Cyman, Piotr, Landowski, Barbara, Kaminska, Krzysztof, Celinski, Zbigniew, Kmiec
Publikováno v:
Cytometry. Part B, Clinical cytometry. 92(2)
Interaction between TL1A and death receptor 3 (DR3) is associated with the pathogenesis of inflammatory bowel disease (IBD), although their role in the development of this disease remains not fully explained. Some studies showed elevated expression o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::451830312323c6a32069e4842f9f7c94
https://pubmed.ncbi.nlm.nih.gov/27001939
https://pubmed.ncbi.nlm.nih.gov/27001939
Autor:
Marcin Stanisławowski, Marcin Matuszewski, Agata Wronska, Piotr M. Wierzbicki, Agata Olejniczak, Zbigniew Kmieć, Jakub Klacz, Agnieszka Rybarczyk, Tomasz J. Slebioda
Publikováno v:
International Journal of Oncology
Clear-cell renal cell carcinoma (ccRCC) is the most common subtype of RCC (70–80%) and is associated with poor prognosis in 40% of cases mainly due to metastasis in the course of the disease. RASSF1, with its isoforms RASSF1A and RASSF1C, is a tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5601f9cfc8c5d0900ab82421aac6a8d8
https://pubmed.ncbi.nlm.nih.gov/26648328
https://pubmed.ncbi.nlm.nih.gov/26648328
Autor:
Sarah L. Buchan, Vadim Y. Taraban, Tomasz J. Slebioda, Sonya James, Adam F. Cunningham, Aymen Al-Shamkhani
Publikováno v:
European Journal of Immunology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c9aec6437a8d4161369eeaeacbde87b
https://doi.org/10.1002/eji.201141950
https://doi.org/10.1002/eji.201141950